These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31871869)

  • 41. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease.
    Barbuti PA; Barker RA; Brundin P; Przedborski S; Papa SM; Kalia LV; Mochizuki H;
    Mov Disord; 2021 Aug; 36(8):1772-1780. PubMed ID: 33963552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models.
    Albert K; Voutilainen MH; Domanskyi A; Airavaara M
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebral function of bone marrow multipotent adult progenitor cells after transplantation in Parkinson's disease rat models.
    Zhang N; Zhou H; Wang H; Yu L; Li Z; Xu H; Wang M
    Transplant Proc; 2013 Mar; 45(2):719-25. PubMed ID: 23498812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contributions of dopaminergic and non-dopaminergic neurons to VTA-stimulation induced neurovascular responses in brain reward circuits.
    Brocka M; Helbing C; Vincenz D; Scherf T; Montag D; Goldschmidt J; Angenstein F; Lippert M
    Neuroimage; 2018 Aug; 177():88-97. PubMed ID: 29723641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats.
    Srinivasan J; Schmidt WJ
    Eur J Neurosci; 2003 Jun; 17(12):2586-92. PubMed ID: 12823465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In Vivo Optogenetic Modulation with Simultaneous Neural Detection Using Microelectrode Array Integrated with Optical Fiber.
    Fan P; Song Y; Xu S; Dai Y; Wang Y; Lu B; Xie J; Wang H; Cai X
    Sensors (Basel); 2020 Aug; 20(16):. PubMed ID: 32823521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
    Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dopaminergic Axons: Key Recitalists in Parkinson's Disease.
    Mishra AK; Dixit A
    Neurochem Res; 2022 Feb; 47(2):234-248. PubMed ID: 34637100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neural grafting for Parkinson's disease: challenges and prospects.
    Stoker TB; Blair NF; Barker RA
    Neural Regen Res; 2017 Mar; 12(3):389-392. PubMed ID: 28469646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.
    Levivier M; Przedborski S; Bencsics C; Kang UJ
    J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
    Datta I; Bhonde R
    Cell Biol Int; 2012 Jul; 36(7):617-24. PubMed ID: 22417707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
    Wang Y; Xia Y; Kou L; Yin S; Chi X; Li J; Sun Y; Wu J; Zhou Q; Zou W; Jin Z; Huang J; Xiong N; Wang T
    Neurobiol Dis; 2023 Aug; 184():106224. PubMed ID: 37433411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.